Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
NLS Days winners announced
Base to Base biotech podcast 31: Exhilarating enzymes and super socks
New company to develop psoriasis monoclonal antibody
DNA nanospring could boost disease diagnosis
Health Canada approves first treatment for Duchenne muscular dystrophy
Neuroblastoma treatment receives Orphan Drug Designation
Base to Base biotech podcast 30: Life sciences in Lithuania
Encouraging results from Canavan disease trial